Nathan Pennock

Research Assistant Professor

Oregon Health & Science University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Nathan Pennock is a Research Assistant Professor at Oregon Health & Science University in the United States. His research areas include immunology, cancer biology, and drug delivery systems, with recent articles focusing on Treg induction, the effects of pharmacologic agents in leukemia, and models of breast cancer progression. Dr. Pennock's work leverages innovative techniques to explore the immunomodulatory effects of various compounds and the molecular profiles associated with cancer outcomes.

Articles (12)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Canping Chen

Oregon Health & Science University

UNITED STATES

View details

Jing Wang

Professor

UNITED STATES

View details

Kelvin MacDonald

Oregon Health & Science University

UNITED STATES

View details

Evan Lind

Associate Professor

Oregon Health & Science University

UNITED STATES

View details

Ross Kedl

Professor

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

Conroy Sun

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nathan Pennock

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Synthesis of ionizable lipopolymers using split-Ugi reaction for pulmonary delivery of various size RNAs and gene editing

Thymically imprinted heterogeneity results in differential Treg induction and stability of effector identity.

T cell-intrinsic immunomodulatory effects of TAK-981 (subasumstat), a SUMO-activating enzyme inhibitor, in chronic lymphocytic leukemia.

Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia.

Isogenic Mammary Models of Intraductal Carcinoma Reveal Progression to Invasiveness in the Absence of a Non-Obligatory In Situ Stage

Nanoscale Hafnium Metal-Organic Frameworks Enhance Radiotherapeutic Effects by Upregulation of Type I Interferon and TLR7 Expression.

Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells

Mammary collagen is under reproductive control with implications for breast cancer.

Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes.

Immune Milieu Established by Postpartum Liver Involution Promotes Breast Cancer Liver Metastasis

S-nitrosylated and non-nitrosylated COX2 have differential expression and distinct subcellular localization in normal and breast cancer tissue.

cDC1 IL-27p28 Production Predicts Vaccine-Elicited CD8+ T Cell Memory and Protective Immunity

Collaborators (6)

Canping Chen

Jing Wang

Kelvin MacDonald

Evan Lind

Ross Kedl

Conroy Sun

Make your next move.